Efficacy of Dupilumab for Patients With Chronic Rhinosinusitis Without Nasal Polyps (CRSsNP)

Condition:   Chronic Sinusitis Interventions:   Biological: dupilumab;   Drug: placebo Sponsor:   Johns Hopkins University Not yet recruiting

Source: ClinicalTrials.gov - April 27, 2020 Category: Research Source Type: clinical trials